Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
02-Oct-24 | Buy | Martin Hellawell | 1,648.00p | 6,000 | £98,880.00 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
02-Oct-24 | Buy | Martin Hellawell | 1,648.00p | 6,000 | £98,880.00 |
Notifier | Holding | Value* |
---|---|---|
Andrew Belshaw | 121,256 | £1,316,840 |
Martin Hellawell | 6,000 | £65,160 |
Charlotta Ginman | 1,000 | £10,860 |
Xavier Robert | 500 | £5,430 |
Notifier** | Holding | Value* |
---|---|---|
Allianz Global Investors GmbH | 9,678,522 | £105,108,749 |
Aggregate of Standard Life Aberdeen plc | 9,470,260 | £102,847,024 |
Liontrust Investment Partners LLP | 9,182,899 | £99,726,283 |
Kames Capital Plc | 5,658,199 | £61,448,041 |
Aggregate of abrdn plc | 5,537,764 | £60,140,117 |
Aggregate of abrdn plc | 5,530,454 | £60,060,730 |
Jupiter Fund Management plc | 4,809,183 | £52,227,727 |
BlackRock, Inc. | 4,808,900 | £52,224,654 |
The Independent Investment Trust PLC | 4,768,647 | £51,787,506 |
Close Asset Management Limited | 4,659,201 | £50,598,923 |
River and Mercantile Asset Management LLP | 4,508,389 | £48,961,104 |
Slater Investments Ltd | 4,470,430 | £48,548,870 |
Aegon N V | 3,793,507 | £41,197,486 |
Currency | UK Pounds |
Share Price | 1,086.00p |
Change Today | 10.00p |
% Change | 0.93 % |
52 Week High | 1,720.00 |
52 Week Low | 1,066.00 |
Volume | 19,903 |
Shares Issued | 92.16m |
Market Cap | £1,000.81m |
Value | ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 6 |
Buy | 3 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 29-May-25 | 19-Sep-24 |
Paid | 19-Jun-25 | 17-Oct-24 |
Amount | 13.00p | 6.50p |
Time | Volume / Share Price |
10:14 | 31 @ 1,086.62p |
10:10 | 6 @ 1,086.00p |
10:05 | 162 @ 1,087.12p |
10:05 | 4 @ 1,086.00p |
10:04 | 1,178 @ 1,086.40p |
CEO | Andrew Belshaw |
CFO | William Castell |
You are here: research